Cashu | Summary

DJI

-0.37%

SPX

+0.27%

IXIC

+0.79%

FTSE

+0.44%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-0.37%

SPX

+0.27%

IXIC

+0.79%

FTSE

+0.44%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

382.61M

Dividend Yield

0.00%

P/E Ratio

NaN

EPS

-1.68

Revenue

237.08M

Avg. Volume

About

What does RVNC do?

Revance Therapeutics, a clinical stage biotechnology company based in Nashville, develops novel botulinum toxin products, including DAXXIFY and the RHA Collection of dermal fillers. The company partners with Viatris and Fosun for biosimilar development and commercialization in China.

Sector

💻 Health Care

IPO

CEO

Employees

597

Headquarters

California, USA

Website

http://www.revance.com